Corbion’s ‘BRIGHT 2030’ strategy focuses on sustainability, clean-label ingredients and nutrition

Corbion, the Amsterdam-listed sustainable food-ingredients company, has announced its strategic roadmap for the coming years, dubbed BRIGHT 2030.

The new strategy, covering the period 2026–2030, is designed to sharpen the company’s focus on sustainable specialty food ingredients for preservation and nutrition while accelerating growth in high-value market segments.

The core of the BRIGHT 2030 strategy centres on capitalising on powerful global trends, particularly increasing consumer demand for clean-label, natural solutions and functional nutrition.

Olivier Rigaud, Corbion CEO, commented on the shift, stating: “BRIGHT 2030 is about sharpening our focus and accelerating innovation and growth where we can make the biggest impact. Our focus on natural food-preservation and nutrition-enhancing ingredients positions us well to win in markets where demand for sustainable, clean-label food solutions is accelerating.”

The new strategy prioritises several areas aimed at driving top- and bottom-line growth:

• Accelerating clean-label preservation: Corbion plans to accelerate the development and application of natural preservation and formulation ingredients in food, aligning with consumer desires for greater transparency and fewer artificial additives. This includes expanding into adjacent food categories such as culinary and seafood
• Expanding algal fermentation: the company will expand its algal fermentation platform beyond existing omega-3 oils, unlocking new opportunities in pet food and human nutrition. This leverages Corbion’s existing expertise to address the growing demand for sustainable nutrient sources
• Strategic review of PLA: the company has initiated a strategic ownership review of its Polylactic Acid (PLA) portfolio, aiming to maintain profitability and operational excellence in the lactic acid-to-PLA value chain.

Corbion has also set aggressive medium-term financial targets for the 2026–2028 period:

Organic sales growth: targeting an annual growth rate of 3–6%.

Adjusted EBITDA margin: targeting a margin of approximately 18% by 2028.

Cumulative free cash flow: projecting €270 million in free cash flow between 2026 and 2028.